Selective laser trabeculoplasty versus 0·5% timolol eye drops in the management of glaucoma in Tanzania

Olusola Olawoye, Daniel Etya'ale

Research output: Contribution to journal › Comment/debate

14 Downloads (Pure)

Access to Document

Selective laser trabeculoplasty versus 0·5% timolol eye drops in the management of glaucoma in Tanzania
Copyright 2021 the authors. This is an open access article published under a Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits distribution and reproduction for non-commercial purposes, provided the author and source are cited.
Final published version, 53.4 KBLicence: CC BY-NC-ND

@article{5ec17acd16ad458980c8404659c98aff,

title = "Selective laser trabeculoplasty versus 0·5% timolol eye drops in the management of glaucoma in Tanzania",

author = "Olusola Olawoye and Daniel Etya'ale",

year = "2021",

month = nov,

doi = "10.1016/S2214-109X(21)00402-2",

language = "English",

volume = "9",

pages = "e1489--e1490",

journal = "The Lancet Global Health",

issn = "2214-109X",

publisher = "Elsevier BV",

number = "11",

}

TY - JOUR

T1 - Selective laser trabeculoplasty versus 0·5% timolol eye drops in the management of glaucoma in Tanzania

AU - Olawoye, Olusola

AU - Etya'ale, Daniel

PY - 2021/11

Y1 - 2021/11

U2 - 10.1016/S2214-109X(21)00402-2

DO - 10.1016/S2214-109X(21)00402-2

M3 - Comment/debate

C2 - 34655546

VL - 9

SP - e1489-e1490

JO - The Lancet Global Health

JF - The Lancet Global Health

SN - 2214-109X

IS - 11

ER -